BioSpace News Archive

– Introduces #Together4Growth to increase awareness of children’s growth disorders, including a four-question Growth Quiz to help parents identify signs and symptoms – – Public encouraged to visit www.together4growth.com and share their growth disorder stories using #Together4Growth – COPENHAGEN, Denmark, Sept. 15, 2020 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative technologies to address unmet medica

As the pandemic continues to grip the US, the nation’s top emergency physicians will gather virtually next month.

Metacrine, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing differentiated therapies for patients with liver and gastrointestinal diseases, announced the pricing of its initial public offering of 6,540,000 shares of its common stock at a public offering price of $13.00 per share.

Benefits offered by safety prefilled syringes, such as more cost-effective processing, ease of use, and elimination of dosing error, and new innovations are major factors that are estimated to propel the safety prefilled syringe system market.

Need to confirm a pregnancy is crucial in animal breeding. It is important to know which ones are getting pregnant and which ones are not in order to determine what the next steps could be.

According to the report, the global endodontic consumables market was valued at ~US$ 1.1 Bn in 2018. It is projected to expand at a CAGR of ~5% from 2019 to 2027.

Cell expansion is used for the production of daughter cells that arise from a single cell. This process is extensively utilized in therapeutic drug development, drug screening, and micro level research of cells.

Alveo Technologies, a leader in developing novel technologies that enable real-time, low-cost, at-home molecular detection of infectious disease, today announced that Fran Soistman has joined the company’s Scientific Advisory Board (SAB)

Funds will Expand Medigate’s Leadership and Availability to Healthcare Organizations Needing Advanced Protection, Visibility and Cost Control

Austria-based medical aesthetic products’ manufacturer Croma-Pharma GmbH establishes new Joint Venture with China National Biotech Group Company Ltd. to market its premium Hyaluronic Acid Filler Princess® VOLUME and various additional aesthetic products of Croma in China and Hong Kong.